Related Experiment Video
Updated: May 22, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Vitamin D receptor signaling inhibits atherosclerosis in mice
Frances L Szeto1, Catherine A Reardon, Dosuk Yoon
1Department of Pathology, Division of Biological Sciences, The University of Chicago, Chicago, Illinois 60637, USA.
Abstract:
Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inactivation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)(-/-)/VDR(-/-) mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR(-/-)/VDR(-/-) mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR(-/-) mice receiving LDLR(-/-)/VDR(-/-) BMT developed larger lesions than LDLR(-/-) BMT controls. Moreover, LDLR(-/-) mice receiving Rag-1(-/-)/VDR(-/-) BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1(-/-) BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1(-/-)/VDR(-/-) BMT and Rag-1(-/-) BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1(-/-)/VDR(-/-) BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.
Insights
Vitamin D receptor (VDR) signaling in macrophages suppresses atherosclerosis by inhibiting the local renin-angiotensin system (RAS). Inactivating VDR accelerates atherosclerosis, highlighting VDR
Area of Science:
- Cardiovascular Biology
- Endocrinology
- Immunology
Background:
- Vitamin D is linked to cardiovascular health, but its role in atherosclerosis via the vitamin D receptor (VDR) is understudied.
- Atherosclerosis involves complex inflammatory processes and lipid metabolism, with potential VDR involvement.
- The renin-angiotensin system (RAS) is implicated in cardiovascular disease, but its interaction with VDR in atherosclerosis is unclear.
Purpose of the Study:
- To investigate the impact of vitamin D receptor (VDR) signaling inactivation on atherosclerosis development.
- To elucidate the anti-atherosclerotic mechanisms of vitamin D, particularly in macrophages.
- To determine the role of the renin-angiotensin system (RAS) in VDR-deficient atherosclerosis.
Main Methods:
- Utilized genetically modified mouse models, including LDLR(-/-)/VDR(-/-) and Rag-1(-/-)/VDR(-/-) mice.
- Employed bone marrow transplantation (BMT) studies to assess VDR function in specific cell types.
- Administered aliskiren, a renin inhibitor, to evaluate the effect on atherosclerosis progression.
Main Results:
- VDR inactivation in mice accelerated atherosclerosis, increasing aortic adhesion molecules and inflammatory cytokines.
- Macrophages lacking VDR exhibited increased renin expression, and aliskiren treatment reduced atherosclerosis in VDR-deficient mice.
- Macrophage-specific VDR signaling was critical for suppressing atherosclerosis, partly through inhibition of local RAS activation.
Conclusions:
- Macrophage VDR signaling plays a crucial role in inhibiting atherosclerosis.
- VDR's anti-atherosclerotic effect is mediated, in part, by suppressing the local renin-angiotensin system within macrophages.
- Targeting VDR or RAS may offer therapeutic strategies for atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
